Cargando…
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
Background: Second-generation thrombopoietin receptor agonists (TPO-RAs) are emerging as the new standard for managing thrombocytopenia (TCP) in patients with chronic liver diseases (CLDs) undergoing scheduled procedures. However, practical guidance for their routine use in CLD patients undergoing s...
Autores principales: | Flisiak, Robert, Antonov, Krasimir, Drastich, Pavel, Jarcuska, Peter, Maevskaya, Marina, Makara, Mihály, Puljiz, Željko, Štabuc, Borut, Trifan, Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625449/ https://www.ncbi.nlm.nih.gov/pubmed/34830701 http://dx.doi.org/10.3390/jcm10225419 |
Ejemplares similares
-
Meeting of Initiative Group for Central European Hepatologic Collaboration (CEHC): Warsaw, 19-21 November 2015
por: Flisiak, Robert
Publicado: (2016) -
Concise Synthesis of (S)-δ-CEHC,
a Metabolite of Vitamin E
por: Burke, Matthew, et al.
Publicado: (2021) -
Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019) -
Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
por: Nakai, Kensaku, et al.
Publicado: (2022) -
Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)